Neoadjuvant treatment of unresectable medullary thyroid cancer with sunitinib.
Cleary
James M
JM
Sadow
Peter M
PM
Randolph
Gregory W
GW
Palmer
Edwin L
EL
Lynch
Thomas P
TP
Nikiforov
Yuri E
YE
Wirth
Lori J
LJ
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018276:Carcinoma, Medullary / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011758:Pyrroles / Q000008:administration & dosage*; D000077210:Sunitinib; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib